智通財經APP獲悉,香港聯交所最新數據顯示,10月6日,董事長兼首席執行官梁文青增持長風藥業(02652)1.93萬股,每股作價6.9216港元,總金額約為13.36萬港元。增持後最新持股數目約為6071.65萬股,持股比例為18.74%。
補充資料:Pursuant to Acting-in-Concert Agreement, Dr. LIANG Bill Wenqing and Dr. LI LI BOVET are parties acting in concert. As such, under the SFO, each of Dr. LIANG and Dr. LI LI BOVET is deemed to be interested in the Shares the other is interested in.